Recently, the company held its annual strategic meeting, focusing on the development blueprint for 2026, and further clarifying the work direction and focus of "re-establishing standards with craftsmanship among all employees to create quality products, and going all out to expand the market to achieve tangible results". The chairman personally presided over the meeting, with all senior executives gathered together, to draw a new chapter of development. The meeting reached a consensus: with the core of re-establishing standards with craftsmanship among all employees to create quality products, and the path of going all out to expand the market to achieve tangible results, the company will be promoted to achieve sustainable and high-quality development.

Quality as the foundation: from product to service, in all aspects

Establishing "craftsmanship standards"

The meeting clearly pointed out that quality is the foundation of enterprise development and the key to winning the market. In 2026, the company will systematically build a quality control system that encompasses all employees, the entire process, and all aspects, focusing on three dimensions: product quality, work quality, and service quality, so that the "spirit of craftsmanship" can truly be integrated into every link.

1. Service quality: Extending from the external to the internal, permeating throughout the entire process

Service quality is not only a commitment to customers, but also a reflection of internal collaboration efficiency. The company requires that a service mindset be integrated into:

① Cross-departmental collaboration: Break down departmental barriers and establish efficient communication and handover mechanisms;

② Process integration: Integrate service standards into the flow of each process to ensure smooth operations;

③ Full participation: Each employee is both a service provider and a beneficiary, forming an internal service loop.

2. Quality assurance: Taking customer satisfaction as the end goal and mechanism construction as the path

To achieve the ultimate goal of "customer trust and sales confidence", the company will focus on promoting:

① Precise demand targeting: Through in-depth research and continuous dialogue, we truly understand the core demands of customers, enabling targeted quality control;

② Peer benchmarking and improvement: Systematically analyze industry benchmarks, identify our own strengths and gaps, and pinpoint areas for focus;

③ Improvement of internal mechanisms: Establish a cross-departmental quality collaboration team to jointly set quantifiable goals, implement supporting assessment and incentive mechanisms, and promote continuous improvement of quality standards.

All of this will rely on the craftsmanship culture of "concentration, focus, and professionalism", making quality no longer a mere slogan but a guiding principle for everyone's actions.

3. Sales breakthrough: Focus on core business segments and fully explore new growth opportunities

Facing market competition, the company has decided to concentrate its advantageous resources on two core business directions: "Protected Amino Acids" and "Cell Culture Media", implementing a market strategy of precise breakthroughs and deep cultivation.

1. Accurate positioning to identify the market breakthrough point

The sales team will conduct in-depth market segmentation and customer persona analysis, focusing on:

Regions with high growth potential;

② Strategic cooperation customers;

③ Emerging application scenarios.

Through differentiated product solutions and flexible cooperation models, we achieve a shift from "wide coverage" to "precise penetration".

2. Strengthen advantages and consolidate core competitiveness

Especially in the field of cell culture media, the company will fully leverage its two major advantages:

① Profound technical accumulation: Leveraging early industry involvement, we have accumulated rich process experience and technical data;

② Stable product quality: Establish a full-process control system from raw materials to finished products to ensure consistency between batches and win long-term trust from customers.

In the future, the company will continue to increase its R&D investment, drive product iteration, and consolidate and expand its leading position in this field.

3. Management empowerment: energizing the organization through refinement

Vigor, uniting team synergy with a sense of responsibility

In his summary, the chairman emphasized that the essence of management lies in serving the business and empowering the team. In 2026, the company will comprehensively promote refined management, focusing on the combination of process control and result orientation to truly enhance organizational operational efficiency.

Strengthen sense of responsibility: By clarifying responsibilities and optimizing processes, enhance employees' sense of ownership towards the results;

Unleash team potential: Encourage cross-departmental collaboration and innovative attempts, allowing each position to maximize its value;

Implementing principal responsibility: As the primary person responsible for achieving objectives, the head of each department needs to proactively embrace the company's strategy, lead the team to focus on key points and overcome difficulties, and effectively inject sustained momentum into the company's development.

2026 is a pivotal year for our company to ascend to a higher development platform. Let us uphold quality with craftsmanship, expand the market with dedication, and unite our team through effective management, jointly writing a brand-new chapter that belongs to us! With unwavering craftsmanship, we will keep moving forward; focusing on breakthroughs, we will strive for mutual success!

four

About Baishixing

Gansu Baishixing Pharmaceutical Co., Ltd. is located in the national-level chemical industrial park - Lanzhou New Area, covering an area of over 90 acres. The company currently employs over 200 staff members, including more than 60 engineering and technical personnel. It is a high-tech enterprise integrating the research, development, production, and sales of protected amino acids, cell culture medium raw materials, bioactive substances, and pharmaceutical intermediates.

The company operates production bases in Chengdu and Lanzhou, and boasts a high-quality, professional management team and technology research and development team. It possesses multiple proprietary intellectual property rights and patented technologies. As one of the leading enterprises in the field of medical raw materials, the company has established stable trade relationships with more than 20 countries and regions worldwide.